B cells and their role in shaping the immune response in squamous cell carcinoma of the head and neck

被引：2
|
作者：
Economopoulou, Panagiota [1 ]
Kotsantis, Ioannis [1 ]
Psyrri, Amanda [1 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Sect Med Oncol, Dept Internal Med 2, Athens, Greece
来源：
IMMUNOTHERAPY | 2021年 / 13卷 / 09期
关键词：
B cells; head and neck cancer; immune checkpoint inhibitors; immunotherapy; T cells; tertiary lymphoid structures; TERTIARY LYMPHOID STRUCTURES; IMMUNOTHERAPY; SURVIVAL;
D O I：
10.2217/imt-2021-0070
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：723 / 726
页数：4
相关论文
共 50 条
  • [31] Immunotherapeutics for head and neck squamous cell carcinoma stem cells
    Qian, X.
    Leonard, F.
    Wenhao, Y.
    Sudhoff, H.
    Hoffmann, T. K.
    Ferrone, S.
    Kaufmann, A. M.
    Albers, A. E.
    HNO, 2020, 68 (02) : 94 - 99
  • [32] The Role of Neck Dissection in Squamous Cell Carcinoma of the Head and Neck
    Marc Hamoir
    Sandra Schmitz
    Vincent Gregoire
    Current Treatment Options in Oncology, 2014, 15 : 611 - 624
  • [33] Heterogeneity of Head and Neck Squamous Cell Carcinoma Stem Cells
    Qian, Xu
    Nie, Xiaobo
    Wollenberg, Barbara
    Sudhoff, Holger
    Kaufmann, Andreas M.
    Albers, Andreas E.
    STEM CELLS HETEROGENEITY IN CANCER, 2019, 1139 : 23 - 40
  • [34] The effect of opioids on the efficacy of immunotherapy in recurrent/ metastatic squamous cell carcinoma of the head and neck
    Scheff, Nicole N.
    Nilsen, Marci L.
    Li, Jinhong
    Harris, Alexandria L.
    Acharya, Rajesh
    Swartz, Andrew
    Hsieh, Ronan W.
    Anderson, Jennifer L.
    Ferris, Robert L.
    V. Menk, Ashley
    Delgoffe, Greg M.
    Zandberg, Dan P.
    ORAL ONCOLOGY, 2023, 140
  • [35] Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neck
    Hanna, Glenn J.
    Liu, Hongye
    Jones, Robert E.
    Bacay, Alyssa F.
    Lizotte, Patrick H.
    Ivanova, Elena V.
    Bittinger, Mark A.
    Cavanaugh, Megan E.
    Rode, Amanda J.
    Schoenfeld, Jonathan D.
    Chau, Nicole G.
    Haddad, Robert I.
    Lorch, Jochen H.
    Wong, Kwok-Kin
    Uppaluri, Ravindra
    Hammerman, Peter S.
    ORAL ONCOLOGY, 2017, 67 : 61 - 69
  • [36] Progress in Immunotherapy of Head and Neck Squamous Cell Carcinoma
    Almokadem, Salah
    CURRENT MOLECULAR PHARMACOLOGY, 2016, 9 (03) : 226 - 230
  • [37] AVPR2 is a potential prognostic biomarker and correlated with immune infiltration in head and neck squamous cell carcinoma
    Mao, Linwei
    Pan, Zhiyong
    Chen, Wenzhi
    Hu, Weiqun
    Chen, Xiufen
    Dai, Huiting
    BMC MEDICAL GENOMICS, 2023, 16 (01)
  • [38] Neoadjuvant immunotherapy for head and neck squamous cell carcinoma
    Kuerten, Cornelius H. L.
    Ferris, Robert L.
    LARYNGO-RHINO-OTOLOGIE, 2024, 103 : S167 - S187
  • [39] Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma
    Wang, Juncheng
    Tian, Yuxi
    Zhu, Gangcai
    Li, Zhexuan
    Wu, Zhisheng
    Wei, Guifang
    Zhuang, Liming
    Li, Zhonghua
    Chen, Xun
    Zhang, Xin
    Zheng, Jinyang
    Cai, Gengming
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 97
  • [40] Boosting the Immune Response with the Combination of Electrochemotherapy and Immunotherapy: A New Weapon for Squamous Cell Carcinoma of the Head and Neck?
    Longo, Francesco
    Perri, Francesco
    Caponigro, Francesco
    Della Vittoria Scarpati, Giuseppina
    Guida, Agostino
    Pavone, Ettore
    Aversa, Corrado
    Muto, Paolo
    Giuliano, Mario
    Ionna, Franco
    Solla, Raffaele
    CANCERS, 2020, 12 (10) : 1 - 11
12345